|
US3274118A
(en)
|
1962-01-22 |
1966-09-20 |
Lithium Corp |
Preparation of stable non-pyrophoric organometallic compositions
|
|
US5721356A
(en)
|
1989-09-15 |
1998-02-24 |
Gensia, Inc. |
Orally active adenosine kinase inhibitors
|
|
US5962473A
(en)
|
1996-08-16 |
1999-10-05 |
Eli Lilly And Company |
Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F
|
|
US6608053B2
(en)
|
2000-04-27 |
2003-08-19 |
Yamanouchi Pharmaceutical Co., Ltd. |
Fused heteroaryl derivatives
|
|
WO2003024441A1
(en)
|
2001-09-14 |
2003-03-27 |
Shionogi & Co., Ltd. |
Novel use of tricyclic compound
|
|
MXPA03005393A
(es)
|
2000-12-19 |
2003-09-25 |
Merck Patent Gmbh |
Formulacion farmaceutica que contiene pirazolo (4,3-d) pirimidinas y antitromboticos, antagonistas de calcio, prostaglandinas o derivados de prostaglandina.
|
|
MXPA05002573A
(es)
|
2002-09-04 |
2005-09-08 |
Schering Corp |
Pirazolopirimidinas como inhibidores de cinasa dependientes de ciclina.
|
|
CA2499639C
(en)
|
2002-09-19 |
2011-11-08 |
Schering Corporation |
Imidazopyridines as cyclin dependent kinase inhibitors
|
|
CA2520323C
(en)
|
2003-04-09 |
2013-07-09 |
Exelixis, Inc. |
Tie-2 modulators and methods of use
|
|
TW200536536A
(en)
|
2004-02-25 |
2005-11-16 |
Schering Corp |
Pyrazolotriazines as kinase inhibitors
|
|
TWI380996B
(zh)
|
2004-09-17 |
2013-01-01 |
Hoffmann La Roche |
抗ｏｘ４０ｌ抗體
|
|
US20060128729A1
(en)
|
2004-11-23 |
2006-06-15 |
Manojit Pal |
Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them
|
|
ES2657443T3
(es)
|
2005-03-25 |
2018-03-05 |
Gitr, Inc. |
Anticuerpos anti-GITR y usos de los mismos
|
|
AU2006244068B9
(en)
|
2005-05-10 |
2012-10-25 |
Incyte Holdings Corporation |
Modulators of indoleamine 2,3-dioxygenase and methods of using the same
|
|
KR101411165B1
(ko)
|
2005-07-01 |
2014-06-25 |
메다렉스, 엘.엘.시. |
예정 사멸 리간드 1 (피디-엘1)에 대한 인간 모노클로날항체
|
|
CA2634198C
(en)
|
2005-12-20 |
2014-06-03 |
Incyte Corporation |
N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
|
|
CL2007002650A1
(es)
|
2006-09-19 |
2008-02-08 |
Incyte Corp |
Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras.
|
|
JP5319532B2
(ja)
|
2006-09-19 |
2013-10-16 |
インサイト・コーポレイション |
インドールアミン２，３−ジオキシゲナーゼのモジュレーターとしてのｎ−ヒドロキシアミジノヘテロサイクル
|
|
CA2667487C
(en)
|
2006-11-06 |
2017-04-04 |
Supergen, Inc. |
Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
|
|
EP1987839A1
(en)
|
2007-04-30 |
2008-11-05 |
I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale |
Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
|
|
US8591886B2
(en)
|
2007-07-12 |
2013-11-26 |
Gitr, Inc. |
Combination therapies employing GITR binding molecules
|
|
EP2044949A1
(en)
|
2007-10-05 |
2009-04-08 |
Immutep |
Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response
|
|
CA2932121A1
(en)
|
2007-11-30 |
2009-06-11 |
Newlink Genetics Corporation |
Ido inhibitors
|
|
CN101952283B
(zh)
|
2007-12-14 |
2013-04-17 |
霍夫曼-拉罗奇有限公司 |
咪唑并[1，2-a]吡啶和咪唑并[1，2-b]哒嗪衍生物
|
|
EP2296789A1
(fr)
|
2008-05-29 |
2011-03-23 |
Saint-Gobain Centre de Recherches et d'Etudes Européen |
Structure en nid d'abeille a base de titanate d'aluminium
|
|
AR072999A1
(es)
|
2008-08-11 |
2010-10-06 |
Medarex Inc |
Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
|
|
PE20100362A1
(es)
|
2008-10-30 |
2010-05-27 |
Irm Llc |
Derivados de purina que expanden las celulas madre hematopoyeticas
|
|
WO2010077634A1
(en)
|
2008-12-09 |
2010-07-08 |
Genentech, Inc. |
Anti-pd-l1 antibodies and their use to enhance t-cell function
|
|
CA2772613C
(en)
|
2009-09-03 |
2020-03-10 |
Schering Corporation |
Anti-gitr antibodies
|
|
US8722720B2
(en)
|
2009-10-28 |
2014-05-13 |
Newlink Genetics Corporation |
Imidazole derivatives as IDO inhibitors
|
|
JP5802676B2
(ja)
|
2009-12-04 |
2015-10-28 |
センワ バイオサイエンシズ インコーポレイテッド |
Ｃｋ２阻害剤としてのピラゾロピリミジンおよび関連複素環化合物
|
|
PL2949670T3
(pl)
|
2009-12-10 |
2019-07-31 |
F. Hoffmann-La Roche Ag |
Przeciwciała wiążące się preferencyjnie z zewnątrzkomórkową domeną 4 ludzkiego CSF-1R i ich zastosowanie
|
|
US9150656B2
(en)
|
2010-03-04 |
2015-10-06 |
Macrogenics, Inc. |
Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof
|
|
US9221910B2
(en)
|
2010-03-05 |
2015-12-29 |
Hoffmann-La Roche Inc. |
Antibodies against human CSF-1R
|
|
US9169323B2
(en)
|
2010-03-05 |
2015-10-27 |
Hoffmann-La Roche Inc. |
Antibodies against human CSF-1R
|
|
AU2011248083B2
(en)
|
2010-05-04 |
2015-09-10 |
Five Prime Therapeutics, Inc. |
Antibodies that bind CSF1R
|
|
MX337040B
(es)
|
2010-09-09 |
2016-02-09 |
Pfizer |
Moleculas de union a 4-1bb.
|
|
WO2012044562A2
(en)
|
2010-09-30 |
2012-04-05 |
Merck Sharp & Dohme Corp. |
Pyrazolopyrimidine pde10 inhibitors
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
GB201103837D0
(en)
|
2011-03-07 |
2011-04-20 |
Oxagen Ltd |
Amorphous (5-Fluoro-2-Methyl-3-Quinolin-2-Ylmethyl-Indol-1-Yl)-acetic acid
|
|
NO2694640T3
(pl)
|
2011-04-15 |
2018-03-17 |
|
|
|
PL2699264T3
(pl)
|
2011-04-20 |
2018-08-31 |
Medimmune, Llc |
Przeciwciała i inne cząsteczki wiążące B7-H1 i PD-1
|
|
JP6222776B2
(ja)
|
2011-04-21 |
2017-11-01 |
オリゲニス ゲーエムベーハーＯｒｉｇｅｎｉｓ Ｇｍｂｈ |
キナ−ゼ・インヒビタ−として有用なピラゾロ［４，３−ｄ］ピリミジン
|
|
EP2785375B1
(en)
|
2011-11-28 |
2020-07-22 |
Merck Patent GmbH |
Anti-pd-l1 antibodies and uses thereof
|
|
US9834755B2
(en)
|
2011-12-08 |
2017-12-05 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
|
|
CA2853889A1
(en)
|
2011-12-15 |
2013-06-20 |
F. Hoffmann-La Roche Ag |
Antibodies against human csf-1r and uses thereof
|
|
BR112014018961A8
(pt)
|
2012-02-06 |
2017-07-11 |
Genentech Inc |
Anticorpo isolado, anticorpo biespecífico, fragmento, ácido nucleico isolado, vetor, célula hospedeira, método de produção de anticorpos, composição farmacêutica, uso do anticorpo, método de tratamento, método de inibição e artigo industrializado
|
|
AR090263A1
(es)
|
2012-03-08 |
2014-10-29 |
Hoffmann La Roche |
Terapia combinada de anticuerpos contra el csf-1r humano y las utilizaciones de la misma
|
|
AR090650A1
(es)
|
2012-04-12 |
2014-11-26 |
Alcon Res Ltd |
Tratamiento para respuestas inflamatorias inducidas por microbios en el ojo
|
|
HK1208233A1
(en)
|
2012-05-11 |
2016-02-26 |
戊瑞治疗有限公司 |
Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
|
|
AR091649A1
(es)
|
2012-07-02 |
2015-02-18 |
Bristol Myers Squibb Co |
Optimizacion de anticuerpos que se fijan al gen de activacion de linfocitos 3 (lag-3) y sus usos
|
|
EP2890398A4
(en)
|
2012-08-31 |
2016-03-09 |
Five Prime Therapeutics Inc |
METHODS OF TREATING DISEASES WITH ANTIBODIES THAT BIND COLONY STIMULATING FACTOR RECEIVER 1 (CSF1R)
|
|
US9637491B2
(en)
|
2012-10-19 |
2017-05-02 |
Origenis Gmbh |
Pyrazolo[4,3-D]pyrimidines as kinase inhibitors
|
|
WO2014138485A1
(en)
|
2013-03-08 |
2014-09-12 |
Irm Llc |
Ex vivo production of platelets from hematopoietic stem cells and the product thereof
|
|
BR112016030690B1
(pt)
*
|
2014-06-27 |
2023-11-14 |
Nogra Pharma Limited |
Compostos moduladores do receptor de arila, composição farmacêutica compreendendo os mesmos e usos terapêuticos dos ditos compostos
|
|
JP2018525345A
(ja)
|
2015-07-01 |
2018-09-06 |
ノースウェスタン ユニバーシティ |
置換キナゾリン化合物及びグルコセレブロシダーゼ活性の調節のためのその使用
|
|
AR109595A1
(es)
|
2016-09-09 |
2018-12-26 |
Incyte Corp |
Compuestos de pirazolopirimidina y usos de estos como inhibidores de hpk1
|
|
CA3057159A1
(en)
|
2017-04-12 |
2018-10-18 |
Magenta Therapeutics Inc. |
Aryl hydrocarbon receptor antagonists and uses thereof
|
|
KR102668371B1
(ko)
*
|
2017-04-21 |
2024-05-28 |
이케나 온콜로지, 인코포레이티드 |
인돌 ahr 억제제 및 이의 용도
|
|
CN113272305A
(zh)
|
2018-10-16 |
2021-08-17 |
医肯纳肿瘤学公司 |
吲哚ahr抑制剂及其用途
|
|
JP2023503167A
(ja)
|
2019-11-26 |
2023-01-26 |
イケナ オンコロジー， インコーポレイテッド |
Ａｈｒ阻害剤およびその使用
|
|
PL4065582T3
(pl)
|
2019-11-26 |
2025-08-18 |
Ikena Oncology, Inc. |
Polimorficzne pochodne karbazolu i ich zastosowania
|
|
JP2023510797A
(ja)
|
2020-01-10 |
2023-03-15 |
イケナ オンコロジー， インコーポレイテッド |
Ａｈｒ阻害剤及びその使用
|
|
WO2022094567A1
(en)
|
2020-10-28 |
2022-05-05 |
Ikena Oncology, Inc. |
Combination of an ahr inhibitor with a pdx inhibitor or doxorubicine
|